Anticoagulant Therapy for 6 Weeks vs 3 Months and Recurrence and Bleeding in Patients Younger Than 21 Years With Provoked Venous Thromboembolism

Anticoagulant Therapy for 6 Weeks vs 3 Months and Recurrence and Bleeding in Patients Younger Than 21 Years With Provoked Venous Thromboembolism—Reply

Published:2022-05-03 Issue:17 Volume:327 Page:1709
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Goldenberg Neil A.¹,Brandão Leonardo R.²,Male Christoph³,

Affiliation:

1. Johns Hopkins University, Johns Hopkins All Children’s Institute for Clinical and Translational Research, St Petersburg, Florida

2. University of Toronto, Toronto, Ontario, Canada

3. Medical University of Vienna, Vienna, Austria

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2791697/jama_goldenberg_2022_lr_220021_1650666712.69612.pdf

Reference6 articles.

1. Effect of anticoagulant therapy for 6 weeks vs 3 months on recurrence and bleeding events in patients younger than 21 years of age with provoked venous thromboembolism: the Kids-DOTT randomized clinical trial.;Goldenberg;JAMA,2022

2. Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.;Male;Lancet Haematol,2020

3. Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial.;Halton;Lancet Haematol,2021

4. Predictors of postthrombotic syndrome in pediatric thrombosis: a systematic review and meta-analysis of the literature.;Engel;J Thromb Haemost,2020

5. Characteristics of upper- and lower-extremity deep vein thrombosis and predictors of postthrombotic syndrome in children.;Avila;Blood Adv,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombosen bei Kindern und Jugendlichen;Pädiatrie;2024-08

2. Thrombotic complications in children with Coronavirus disease 2019 and Multisystem Inflammatory Syndrome of Childhood;Journal of Thrombosis and Haemostasis;2023-09

3. Direct oral anticoagulants in pediatric venous thromboembolism: Review of approved products rivaroxaban and dabigatran;Frontiers in Pediatrics;2022-10-13